Salivary gland dysfunction is a common side effect of cancer treatments. Salivary function
plays key roles in critical daily activities. Consequently, changes in salivary function can …

Alpha theranostics offer an attractive alternative form of therapy, which has best been
investigated and documented with 225 Ac-PSMA in patients with prostate cancer …

Patients with relapsed or refractory metastatic cancer unresponsive to standard therapies
have motivated nuclear physicians to develop innovative radioligands, precisely targeted to …

The aim of this work is to evaluate our clinical real-world data obtained with 225 Ac-PSMA-
617 (AcPSMA), which were acquired under compassionate care regulations in patients with …

Liver metastases from prostate cancer are associated with an aggressive disease course
and poor prognosis. Results from autopsy studies indicate a liver metastasis prevalence of …

Prostate cancer (PCa), a leading global health concern, profoundly impacts millions of men
worldwide. Progressing through two stages, it initially develops within the prostate and …

Prostate cancer (PCa) is the most prevalent malignancy and leading cause of mortality in
men. Despite the development of various drugs, such as novel androgen receptor signaling …

The theragnostic approach was proposed with the introduction of 131-Iodine for the
treatment of both benign and malign thyroid diseases [1–5]. The therapeutic effect of 131 …

Iran has had many achievements in recent years in producing different diagnostic and
therapeutic radiopharmaceuticals [1]. Presence of over 210 nuclear medicine centers and …